FromAstraZeneca ([email protected])
Subject (72)Tezspire approved in the US for chronic rhinosinusitis with nasal polyps
Preheader (72)Tezspire approved in the US for chronic rhinosinusitis with nasal polyps
Arial
Text Analysis
Body Words133
Subject Words11
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px744 px
X-Spam Score1.0
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeAfternoon
